Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-KAD for Asteroid Hyalosis
NCT00825942Phase 2Unknown
- Sponsor
- Chakshu Research, Inc.
- Start
- Jul 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ethylenediaminetetraacetic acid in asteroid hyalosis (AH), sponsored by Chakshu Research, Inc. Primary endpoint: Reduction in the number of asteroid bodies at 180 days. Status: unknown.
02
Drugs
ethylenediaminetetraacetic acid
03
Conditions
asteroid hyalosis (AH)
Beyond the preview
Go deeper on NCT00825942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825942.